Screener
Bausch Health Companies BHC Salix — Goodwill, impairment loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| (in millions) | Salix | International | Solta Medical | Diversified | Bausch + Lomb | Total |
|---|---|---|---|---|---|---|
| Impairment | — | — | — | (145) | — | (145) |
| Goodwill reclassified to assets held for sale | — | (4) | — | — | — | (4) |
| Foreign exchange and other | — | 109 | — | (33) | 138 | 214 |
| Balance, December 31, 2025 | 3,159 | 897 | 137 | 1,581 | 5,497 | 11,271 |
| Additions | — | — | — | — | — | — |
| Impairment | (1,426) | — | — | — | — | (1,426) |
| Foreign exchange and other | — | (17) | — | — | (21) | (38) |
| Balance, March 31, 2026 | $1,733 | $880 | $137 | $1,581 | $5,476 | $9,807 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's salix — goodwill, impairment loss?
- Bausch Health Companies (BHC) reported salix — goodwill, impairment loss of $1.43B in Q1 2026.
- What does salix — goodwill, impairment loss mean?
- Measures the reduction in the carrying value of goodwill within the Salix segment when its fair value falls below its book value. This charge indicates that the expected future economic benefits from previous acquisitions in this segment have declined. It serves as a critical indicator of potential overpayment for past assets or deteriorating market conditions in the gastroenterology sector.
Ask your AI about Bausch Health Companies's salix — goodwill, impairment loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude